Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
The clinical outcomes and survival of tyrosine kinase inhibitor (TKI)-treated patients with chronic myeloid leukemia (CML) have been significantly improved. The aim of this editorial is to outline critical steps of TKI administration practices during the long-term clinical course of CML based on dat...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Galenos Publishing
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878539/ |